In pharmacokinetic (PK) studies comparing furosemide with metallo-furosemide (“MCP-111”)
rats dosed orally with the solid test material, we have demonstrated up to 62% increase
in Cmax with MCP-111, a consistent decrease in tmax and 2.4-fold reduction in inter-subject
variability. The graph below shows an example of one of these pharmacokinetic studies.